Although SARS-CoV-2 vaccines immunogenicity in patients with cancer has been investigated, whether they can significantly improve the severity of COVID-19 in this specific population is undefined.

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

Santoro, Armando;Rimassa, Lorenza;
2022-01-01

Abstract

Although SARS-CoV-2 vaccines immunogenicity in patients with cancer has been investigated, whether they can significantly improve the severity of COVID-19 in this specific population is undefined.
2022
Inglese
171
64
74
11
COVID-19
Cancer
Clinical efficacy
Prevention
SARS-CoV-2
Vaccines
COVID-19 Testing
COVID-19 Vaccines
Humans
Morbidity
SARS-CoV-2
Vaccination
COVID-19
Neoplasms
Sì
Pinato, David J; Ferrante, Daniela; Aguilar-Company, Juan; Bower, Mark; Salazar, Ramon; Mirallas, Oriol; Sureda, Anna; Bertuzzi, Alexia; Brunet, Joan;...espandi
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
51
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/68346
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 28
social impact